These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2445078)

  • 21. Methotrexate in rescue therapy for xenotransplanted lungs in primates.
    Takeda M; Kawauchi M; Nakajima J; Furuse A
    Transplant Proc; 1996 Apr; 28(2):792-3. PubMed ID: 8623402
    [No Abstract]   [Full Text] [Related]  

  • 22. FK 506--an investigational immunosuppressant.
    Med Lett Drugs Ther; 1991 Oct; 33(854):94. PubMed ID: 1716722
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
    Woodle ES; Thistlethwaite JR; Haas M; Josephson MA; Newell KA; Bruce DS; Millis JM; Piper JB; Charette JI
    Transplant Proc; 1996 Apr; 28(2):998-9. PubMed ID: 8623495
    [No Abstract]   [Full Text] [Related]  

  • 24. Current advantage of FK 506 in cadaveric kidney transplantation.
    Ciancio G; Rosen A; Loreto-Grand B; Burke G; Siquijor A; Luque C; Esquenazi V; Miller J
    Transplant Proc; 1996 Apr; 28(2):1000-1. PubMed ID: 8623207
    [No Abstract]   [Full Text] [Related]  

  • 25. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FK 506-based immunosuppression in clinical pancreas transplantation.
    Swanson C; Rubin M; Colquhoun S; Basadonna G; Asshinnik A; Perez R
    Transplant Proc; 1995 Dec; 27(6):3031. PubMed ID: 8539827
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of a novel immunosuppressive agent, FK-506, on islet allograft survival in the rat.
    Yasunami Y; Ryu S; Kamei T; Konomi K
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2720. PubMed ID: 2468234
    [No Abstract]   [Full Text] [Related]  

  • 28. Different immunosuppressive effects of liposomal FK506 in liver and kidney transplantation.
    Ko S; Nakajima Y; Kanehiro H; Horikawa M; Yoshimura A; Kido K; Taki J; Aomatsu Y; Kin T; Yagura K; Ohyama T; Ohashi K; Yamada T; Nakano H
    Transplant Proc; 1996 Apr; 28(2):1066-8. PubMed ID: 8623229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 15-Deoxyspergualin as an immunosuppressive agent in dogs.
    Amemiya H; Suzuki S; Manabe H; Fukao K; Iwasaki Y; Dohi K; Isono K; Orita K; Yamanaka N
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):229-32. PubMed ID: 3279613
    [No Abstract]   [Full Text] [Related]  

  • 30. Reversal of accelerated renal allograft rejection with FK 506.
    Woodle ES; Newell KA; Haas M; Bartosh S; Josephson MA; Millis JM; Bruce DS; Piper JB; Aronson AJ; Thistlethwaite JR
    Clin Transplant; 1997 Aug; 11(4):251-4. PubMed ID: 9267710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal transplantation in baboons under FK 506.
    Imventarza O; Todo S; Eiras G; Ueda Y; Furukawa H; Wu YM; Zhu Y; Oks A; Demetris J; Starzl TE
    Transplant Proc; 1990 Feb; 22(1):64-5. PubMed ID: 1689903
    [No Abstract]   [Full Text] [Related]  

  • 32. Prolonged limb allograft survival with short-term treatment with FK-506 in rats.
    Arai K; Hotokebuchi T; Miyahara H; Arita C; Mohtai M; Sugioka Y; Kaibara N
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3191-3. PubMed ID: 2468256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FK 506 induction and rescue therapy in pancreas transplant recipients.
    Stratta RJ; Taylor RJ; Castaldo P; Sindhi R; Sudan D; Weide LG; Frisbie K; Cushing KA; Jerius J; Radio SJ
    Transplant Proc; 1996 Apr; 28(2):991-2. PubMed ID: 8623492
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of the immunosuppressive and toxic effects of FK506 and cyclosporine in xenograft recipients.
    Gudas VM; Carmichael PG; Morris RE
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1072-3. PubMed ID: 2468211
    [No Abstract]   [Full Text] [Related]  

  • 35. [Everolimus: immunosuppression with antilymphoproliferative therapy].
    Pascual J
    Nefrologia; 2004; 24(2):112-23. PubMed ID: 15219086
    [No Abstract]   [Full Text] [Related]  

  • 36. Experimental and clinical experience with the use of tacrolimus (FK506) in kidney transplantation.
    Wagner K; Herget S; Heemann U
    Clin Nephrol; 1996 May; 45(5):332-5. PubMed ID: 8738666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Japanese multicenter studies of FK 506 in renal transplantation. Japanese FK 506 Study Group.
    Ochiai T; Ishibashi M; Fukao K; Takahashi K; Endo T; Yokoyama I; Uchida K; Ohshima S; Takahara S; Morozumi K
    Transplant Proc; 1995 Feb; 27(1):50-3. PubMed ID: 7533419
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclosporine in transplantation of the liver in the dog.
    Williams JW; Peters TG; Haggitt R; Van Voorst S
    Surg Gynecol Obstet; 1983 Jun; 156(6):767-73. PubMed ID: 6344281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunopharmacology of FK-506.
    Morris RE; Hoyt EG; Murphy MP; Shorthouse R
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1042-4. PubMed ID: 2468201
    [No Abstract]   [Full Text] [Related]  

  • 40. Monitoring of FK 506 blood levels in kidney transplant recipients.
    Takahara S; Kokado Y; Kameoka H; Takano Y; Jiang H; Moutabarrik A; Ishibashi M; Okuyama A; Sonoda T
    Transplant Proc; 1994 Aug; 26(4):2106-8. PubMed ID: 7520623
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.